Gauting, Germany

Burkhard Goke

This inventor holds 1 USPTO granted patent. Top assignee: Amylin Pharmaceuticals, Inc.. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Burkhard Goke. Retrieved from https://idiyas.com/inventor/burkhard-goke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 141(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Burkhard Goke: Innovator in Appetite Control

Introduction

Burkhard Goke is a notable inventor based in Gauting, Germany. He has made significant contributions to the field of appetite control through his innovative research and patenting efforts. His work focuses on the development of compounds that can effectively manage human appetite.

Latest Patents

Goke holds a patent for "Human appetite control by glucagon-like peptide receptor binding compounds." This patent describes a composition that includes a compound which binds to a receptor for glucagon-like peptide-1, along with a pharmaceutical carrier. The amount of the compound present is effective in controlling appetite in humans. Additionally, the patent discloses a method for reducing food intake by administering this composition to individuals.

Career Highlights

Burkhard Goke has been associated with Amylin Pharmaceuticals, Inc., where he has contributed to the advancement of pharmaceutical solutions aimed at appetite regulation. His work has the potential to impact the treatment of obesity and related health issues.

Collaborations

Goke has collaborated with notable colleagues in his field, including Christoph Beglinger and Thomas R. Coolidge. These partnerships have likely enhanced the research and development of appetite control solutions.

Conclusion

Burkhard Goke's innovative work in appetite control through glucagon-like peptide receptor binding compounds showcases his commitment to advancing medical science. His contributions are paving the way for new treatments that could significantly benefit individuals struggling with appetite regulation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…